Concepedia

Georg Kralidis

GK

9

Publications

668

Citations

9

H-Index

2003

Active since

Affiliations

Novartis (Switzerland)(Current)

University Hospital of Zurich

University Hospital of Lausanne

Aalborg University Hospital

University Hospital of Bern

Georg Kralidis is an author at Novartis (Switzerland) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

2003–2019

9

Publications

9

A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M <sub>3</sub> selective receptor antagonist, in the treatment of overactive bladder

Christopher R. Chapple, William D. Steers, Peggy Norton et al. · British Journal of Urology · 2005 · 131 citations

Impact of Antiviral Preventive Strategies on the Incidence and Outcomes of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Oriol Manuel, Georg Kralidis, Nicolas J. Mueller et al. · American Journal of Transplantation · 2013 · 113 citations · Full text

Long-term Results of Surgery For Urethral Stricture: A Statistical Analysis

Thomas M. Kessler, F. Schreiter, Georg Kralidis et al. · The Journal of Urology · 2003 · 96 citations

An investigation of dose titration with darifenacin, an M <sub>3</sub> ‐selective receptor antagonist

William D. Steers, Jacques Corcos, Jenelle E. Foote et al. · British Journal of Urology · 2005 · 92 citations

Treatment of Overactive Bladder in the Older Patient: Pooled Analysis of Three Phase III Studies of Darifenacin, an M3 Selective Receptor Antagonist

Jenelle E. Foote, Karin Glavind, Georg Kralidis et al. · European Urology · 2005 · 81 citations

, , +7

Rows per page

1–5 of 9